Celebrating International Clinical Trials Day

Dr Qamar is a neurology clinical and academic fellow at King’s College Hospital in movement disorders and neurology, at the Parkinson’s Centre of Excellence. He also works at the Centre of Healthy Ageing, at King’s College London. Dr Qamar has been working in the field of Parkinson’s and Dementia research for over 7 years. He has been delivering and overlooking the delivery of clinical trials as a Chief Investigator, Principal Investigator, and Sub Investigator for trials ranging from Phase I to Phase IV. Dr Qamar has a particular interest in early-phase drug trials and investigator-led initiatives. Dr Qamar has a background in neuroscience, medical ethics and law, medical education, and Philosophy and Theology.

As a clinical trials fellow working in blood cancers and bone marrow transplant, I have the privilege of being at the forefront of research that is transforming how we treat, and even cure, cancer. In this talk, I’ll share how modern clinical trials are no longer just about testing new drugs, but about designing smarter treatments that work with the body’s own immune system.
We’ll explore how immunotherapy – using our body’s own immune cells - is reshaping the landscape of blood cancer treatment. I’ll also explain how we develop clinical trials, what makes a trial successful, and how patients play a crucial role in helping us move science forward.
Whether you're a curious listener or someone with a personal connection to cancer, this talk is about hope, progress, and the future of medicine—all powered by the immune system.